There are several species of alternatively spliced fibronection (FN). One of these, FN EIIIB, is primarily present in embryonic and in proliferating and migrating cells and is believed to be important for cell maturation. We have studied the syntheris, localization, and secretion of this FN isoform in isolated guinea pig megakaryocytes, nonmegakaryocytic bone marrow cells, and platelets. There was 7.5 times more general FN yocytes were shown to synthesize FN EIIIB and other FN isoforms. FN EIIIB is translocated to the cell surface but not secreted in response to thrombin, while other FN isoforms are both translocated to the surface and secreted. Megakaryocytes are among the few adult cells that contain significant quantities of FN EIIIB. Thus, FN EIIIB may have a specific role in megakaryocyte matrix interactions. The expression of FN isoforms may be important for megakaryocyte maturation as well as being a source for platelet FN.
been detected, and these isoforms are produced by altemative splicing of a single gene transcript. FN consists of a series of homologous repeats of amino acids, and three types of similar sequences can be identified (types I to 111). Several segments within the type 111 repeats, exons IIIA and IIIB and a variable region (V-region), can be subjected to alternative splicing. Alternative splicing can result in the inclusion or omission of exon IIIA and/or exon IIIB, producing FN EIIIA+B+, FN EIIIA+B-, FN EIIIA-B+, or FN EIIIA-B-. Cellular and matrix FN and immature or migrating cells are more likely to contain one or both of these exons. Several isoforms can be produced by altemative splicing of the V-region. In platelets, alternatively spliced variants of the V-region have been detected. One variant is not secreted, another is more likely to be a cellular form, and another i s released into plasma and can be incorporated into blood clots.' Alternatively spliced FN EIIIB has been detected in platelets.* This study demonstrated that megakaryocytes contain FN EIIIB, while this FN isoform was not detected in nonmegakaryocytic bone marrow hematopoietic cells. Also, megakar- yocytes were shown to synthesize FN EIIIB and other FN isoforms. FN EIIIB is translocated to the cell surface but not secreted in response to thrombin, while other FN isoforms are both translocated to the surface and secreted. Megakaryocytes are among the few adult cells that contain significant quantities of FN EIIIB. Thus, FN EIIIB may have a specific role in megakaryocyte matrix interactions. The expression of FN isoforms may be important for megakaryocyte maturation as well as being a source for platelet FN.
MATERIALS AND METHODS

Preparation of Cells
Guinea pig megakaryocytes were isolated to about 85% purity by cell number and to greater than 98% by protein content or cell volume, as megakaryocytes are considerably larger than other cells.9-" Nonmegakaryocytic bone marrow hematopoietic cells were prepared and served as controls." The viability of the isolated cells was about 89%. Platelets were prepared as previously described."
Fibroblasts, cells that have extensive capacity for the synthesis of FN isoforms, and macrophages are not isolated by our procedure and do not contaminate the megakaryocyte preparations."
Antibodies
Affinity-purified rabbit anti-human fibronectin that reacts with both plasma and cellular FN isoforms was used to assess general FN (F3648; Sigma Chemical CO, St 
Demonstration of Endogenous FN and FN EIIIB
Guinea pig megakaryocytes, platelets, and plasma were treated with 2% Tris-sodium dodecyl sulfate (SDS) in the presence of phenylmethylsulfonyl fluoride (PMSF, 1 mmol/L), aprotinin (2.7 pmol/ L), and EDTA (1 mmol/L). Epsilon aminocaproic acid (EACA, 0.05 m o m ) was also used when FN was isolated from plasma. For the assessment of FN, plasma, platelet, and megakaryocyte proteins were separated by 7.5% reduced polyacrylamide gel electrophoresis (PAGE). Immunostained fibronectin in Western blots was detected by a horseradish peroxidase-labeled second antibody using enhanced chemiluminescence (ECL) (Amersham Life Science, Arlington Heights, IL).
For the evaluation of regulated secretion, megakaryocytes in calcium and magnesium-free Hank's balanced salt solution (CMFH), pH 7.4, and platelets in Dulbecco's phosphate buffer with 1 mmoV L calcium, pH 7.4, were incubated with thrombin (0.1 to I .O U/mL) for 2 minutes at 37°C. Megakaryocytes were not stirred, but platelets were stirred in these experiments. Secreted FN was assessed in the suspension medium by Western blotting using 7.5% reduced gels and was visualized by ECL. To obtain quantitative data, the relative intensity of the ECL-visualized bands was determined by densitometry (Camag TLC Scanner 11, Muttenz, Switzerland).
Immunocytochemistry and Confocal Microscopy
Resting megakaryocytes and megakaryocytes treated with thrombin as described above were studied. To obtain a positive control for surface-located proteins, megakaryocytes were treated for 5 minutes at room temperature with fluorescein isothiocyanate (FITC)-labeled wheat germ agglutinin, 1.4 pmol/L, without stimng." The sample was then diluted with calcium and magnesium-free Hanks' balanced salt solution containing adenosine and theophylline (CMFH & A & T), centrifuged briefly, and resuspended in CMFH & A & T containing propidium iodide (1 pg/mL) to identify nuclei.
Megakaryocytes in CMFH & A & T were allowed to settle on polylysine-coated (mol wt, 53,900 D) coverslips for 20 minutes at 37°C. An aliquot of 100 pL containing 15 x lo3 cells was applied to each coverslip. To identify nuclei, propidium iodide (1 pg/mL) was added to the cell suspension before aliquoting. The coverslips were washed with CMFH & A & T, treated at 4°C with 70% ethanol for 5 minutes, and then washed again before covering with PBS and storing at 4°C for up to 2 weeks.
Megakaryocytes on coverslips were preincubated with 4% goat serum or 1% bovine serum albumin (BSA) for 30 minutes at 37"C, washed, and then incubated with antibodies to FN, FN EIIIB (mentioned above), or vWF (F-3520; Sigma) in PBS containing 1% goat serum or BSA. After washing, the coverslips were incubated with goat anti-rabbit IgG-labeled with FITC (Cappel, Durham, NC), washed again, and mounted over fluorescence-preserving glycerol-PBS mounting solution (Kirkegaard and Perry Laboratories, Gaithersberg, MD). Control samples were incubated with nonimmune rabbit IgG instead of the first antibody.
Specimens were visualized with a BioRad MRC-600 krypton-argon laser confocal microscope (BioRad, Melville, NY) adapted to a Zeiss Axiovert 100 inverted microscope equipped with a Zeiss 63X Plan Apo (NA 1.4) lens (Zeiss,
Preparation of slides.
Immunostaining.
Confocal microscopy.
Thomwood, NJ). Confocal microscopy allowed us to take about 0.4-pm thin sections through the cells. The overall thickness of the cells was about 7 pm.
Synthesis and Constitutive Secretion of FN
Isolated megakaryocytes were incubated with Expre3% ?S (New England Nuclear, Boston, MA) at 100 pCi/mL of medium. The incubations were performed at several time points up to 17 hours. Megakaryocytes were pelleted by centrifugation and lysed at room temperature in 2% Tris-SDS in the presence of EDTA (4 mmol/L), PMSF (1 mmoVL), iodoacetic acid (2 mmol/L), N-Ethylmaleimide (NEM) (2 mmoVL), leupeptin (0.1 mmol/L), and aprotinin (2.7 pmol/L). Newly synthesized FN was immunoprecipitated by the incubation of the lysate with batch Protein A beads (P-1406; Sigma) that had been coupled with anti-FN antibody. FN was separated by unreduced 7.5% PAGE, and newly synthesized FN was detected by autoradiography. For the assessment of constitutive secretion of FN, radiolabeled FN secreted into the incubation medium was immunoprecipitated as described above, separated by unreduced 7.5% PAGE. and analyzed by autoradiography.
RES U LTS
Westem blot analysis with ECL demonstrated the relative amounts of FN in megakaryocytes and in nonmegakaryocytic hematopoietic bone marrow cells. Figure 1A is a Westem blot of a representative experiment in which FN was identified by an antibody that recognizes both cellular and plasma FN. Protein from a varying number of megakaryocytes, ranging from 5 X lo3 to 50 X lo3 cells, was applied to lanes 1 through 4, and protein from varying numbers of nonmegakaryocytic bone marrow cells, ranging from 5 x lo3 to 2 X lo6 cells, was applied to lanes 6 through 11. Immunostained FN was linear to the amount of cellular protein applied. Densitometric analysis suggested that the amount of immunoreactive FN in 10 x io3 megakaryocytes was equivalent to that in about 750 X lo3 nonmegakaryocytic bone marrow hematopoietic cells. The cell volume and protein content of megakaryocytes are about 10 times greater than those of nonmegakaryocytic cells. Thus, based on equivalent protein content, megakaryocytes contain 7.5 times more general FN than nonmegakaryocytic bone marrow cells.
Purified megakaryocytes contained about 15% nonmegakaryocytic cells. Based on the data in To obtain quantitative data, the relative intensity of FN on Western-ECL blots from different numbers of intact megakaryocytes was quantified by densitometry. A representative experiment is shown in Fig 3 and demonstrates the relative intensity of FN in 5 X IO', IO X IO3, and 20 X IO.' intact megakaryocytes. To determine the amount that was secreted, the relative intensity of FN released into incubation medium from 25 X IO' megakaryocytes was compared with that present in intact megakaryocytes in the same experiment. The densitometric analysis of three experiments revealed that thrombin induced the release of 25.3% ? 4.6% (mean & SD) FN in megakaryocytes.
Not shown are similar experiments that showed that thrombin can induce the release of FN from platelets. In response to thrombin, 59% and 64% general platelet FN was released in two experiments.
FN ElIIB was found to be present in megakaryocytes and platelets, as shown in Lanes 1 through 5 in Fig 4B demonstrate FN EIIIB present in 5 X IO", 10 X IO' , 25 X IO", 50 X IO", and 100 X IO", platelets, respectively. The amount of immunoreactive FN ElllB was linear to the number of cells applied. After thrombin treatment, there was no FN ElllB in the volume of incubation medium that had contained 100 X IO3 megakaryocytes or 200 X IO" platelets, as shown in lanes 6 in Fig 4A  and B, respectively. These data indicate that FN EIIIB is not released in response to thrombin. The experimental protocol would have detected 5% of megakaryocyte and 2.5% of platelet FN ElIlB had it been released, based on the fact that FN ElllB was detectable in 5 x IO3 megakaryocytes and in 5 x 10' platelets. Figure 4C demonstrates the densitometric assessment of the data in lanes 2 through 5 in Fig 4A and lanes I through  4 in Fig 4B and revealed that the relative intensity of the bands was linear. Lane 5 in Fig 4B was not assessed because the intensity was beyond the sensitivity of the densitometer. Figure 4C indicates that platelets contained about 60% more FN EIllB than megakaryocytes when equivalent amounts of protein from megakaryocytes and platelets were compared by assessing 1,000-fold more platelets than megakaryocytes."
To determine the localization of FN and FN EIIIB, resting and thrombin-treated megakaryocytes were immunostained with either anti-FN ElIIB or anti-general FN antisera, and cytoimmunofluorescence was assessed by confocal microscopy. The nucleus was visualized with propidium iodide in cells shown in Fig 5A through D overall thickness of the cells shown in Fig S was about 7 pm. Serial sections of about 0.4 pm were analysized by confocal microscopy. and sections through the center of megakaryocytes are shown. Figure SA demonstrates FN EIllB that was homogenously dispersed in the cytosol in a resting megakaryocyte. Figure SB displays a control in which nonimmune IgG was substituted for the first antibody and only nuclear staining with propidium iodide was evident. A control to demonstrate the appearance of surface-located proteins is shown in Fig SC. in which megakaryocytes had been incubated with FITC-conjugated wheat germ agglutinin (FITC-WGA). The localization of FN EllIB (Fig SD) and  general FN (Fig SE) in thrombin-treated megakaryocytes was similar to the surface localization of FITC-WGA shown in Fig SC. The formation of patches of general FN on the surface of a thrombin-treated megakaryocyte was evident in Fig SE. Thus, thrombin induced the redistribution of both FN EllIB and general FN to the megakaryocyte surface. In contrast, thrombin did not cause any changes in distribution of vWF in megakaryocytes, as shown in Fig SF. The study indicates that FN and FN EIIIB are synthesized in megakaryocytes based on metabolic labeling. Figure 6 is an autoradiogram of one of five experiments in which FN synthesis was studied and FN and FN EllIB were immunoprecipitated. Newly synthesized FN was separated by a 7 3 % unreduced SDS-PAGE. FN dimers (440 to 450 kD) and, to a lesser extent, monomers (220 to 225 kD) were synthesized in megakaryocytes as shown in the lane on the left. The synthesis of FN EIllB is demonstrated in the right lane. The radioactive bands in the stacking gel under unreduced conditions were not present in reduced gels. Based on their location and behavior after reduction, the bands in the stacking gel most likely were newly synthesized FN multimers.'" Less than S% of general FN and no FN EIllB was detected in the incubation medium after overnight incubations. About the same amount of cytosolic protein is released due to cell death under these conditions, and therefore, there appears to be little if any significant constitutive secretion of FN and FN EIIIB from megakaryocytes.
DISCUSSION
Alternatively spliced FN EIllB was detected in guinea pig megakaryocytes and platelets. Most studies have demonstrated a limited distribution of FN EllIB in adult tissues. mRNA for FN EIllB was detected in rat brain. heart, kidney, and testis, but not in liver, skeletal muscle, and spleen." FN EIIIB has been found in adult articular The distribution of a related alternatively spliced FN, FN EIIIA, is also limited but may be more ubiquitous than FN EIIIB. or FN EIIIB in plasma is secondary to secretion or cell damage. '' This study demonstrates that megakaryocytes can synthesize general FN and FN EIIIB. Previous studies indicate that plasma is not a likely source of platelet FN.'.s The absence of ElllB in granulocytes also indicates that this isoform is not endocytosed, as granulocytes contain granules that are capable of endocytosis.x Therefore, biosynthesis of FN and FN EIIIB by megakaryocytes is the most likely source of these FN isoforms in megakaryocytes and platelets.
Constitutive secretion of general FN and ED-I (FN EIIIA)''' and vWF'~ has been demonstrated in cultured endothelial cells. The current study indicates that FN and FN EIIIB are not constitutively secreted in guinea pig megakaryocytes. However, this is not the case for other megakaryocyte proteins, because constitutive secretion of vWF occurs in megakaryocytes." Thus, FN, although synthesized, is not constitutively secreted in megakaryocytes.
Significant amounts of general FN (25.3% in megakaryocytes and about 61 5% in platelets) were secreted in response to thrombin. Interestingly, thrombin did not cause the secretion of FN EIIIB into the incubation medium. Nevertheless, thrombin appears to induce the redistribution of both FN EIIIB and general FN to the surface of megakaryocytes, as assessed by confocal microscopy. Consistent with our findings is evidence that platelet FN is relocated to the surface, as well as secreted into the medium in response to thrombin.' The absence of secretion of FN EIIIB is consistent with the experience with FN species in other cells in that certain isoforms are secreted into the medium. while other isoforms are translocated and primarily bind to the cell surface.' Thus, general FN is secreted and bound to the surface of both megakaryocytes and platelets, while FN EIIIB binds to the megakaryocyte surface but is not secreted. Releasibility in response to thrombin has been used as a criterion for identifying proteins stored in platelet alpha granules." Most likely. both FN and FN EIIIB are released from storage sites. probably alpha granules, in response to thrombin.
FN may have a unique role in the maturation of hematopoietic cells. FN has been detected in bone marrow matrix but its distribution differs from type I collagen. FN forms septa in bone marrow that may provide anchorage for migrating hematopoetic progenitor cells." There is evidence that erythroid progenitor cells and possibly other hematopoietic precursor cells adhere to FN at an early phase of maturation, and FN may thereby influence migration and maturation of these cells.'"~" Reticulocytes can bind to FN, but this activity is lost as reticulocytes mature and may be instrumental for the release of reticulocytes into the circulation." A role for FN in megakaryocyte maturation and platelet production is suggested by the expression of FN in fetal liver megakaryocytes before its expression in fetal hepatocytes." FN is involved in megakaryocyte spreading3" and proplatelet fromation." Pronectin, an artificial RGD FN matrix, supports megakaryocyte maturation far better than Matrigel."
Our study indicates that megakaryocytes have considerably more general FN than do nonmegakaryocytic bone marrow hematopoietic cells. It is intriguing that megakaryocytes and not nonmegakaryocytic bone marrow hematopoieitic cells contain FN EIIIB. Fibroblasts are the major source of FN isoforms in matrices.' However, the FN composition of matrices may be modified by the production of FN isoforms by megakaryocytes.
Further studies are necessary to define the role of general FN and altematively spliced FN EIIIB in megakaryocytes. FN isoforms do not appear to be constitutively secreted, but appropriate stimuli, possibly thrombopoietin or selected cytokines, may induce regulated secretion of FN. Conceivably, FN secreted from megakaryocytes may alter the megakaryocyte pericellular environment and influence megakaryocyte-matrix interaction and, therefore, megakaryocyte migration and maturation. The emergence of FN EIIIB on the megakaryocyte surface may have a unique role in this regard as it is not present in other bone marrow hematopoietic cells. FN present in megakaryocytes may have a dual role in thrombopoiesis and platelet activities, one being a For personal use only. on October 23, 2017. by guest www.bloodjournal.org From role in megakaryocyte-matrix interactions and megakaryocyre maturation, and the other being a source for platelet m.
